GHA waits for guidance as UK greenlights weight-loss jab to prevent heart attacks and strokes
By Gabriella Peralta and PA Staff The GHA is awaiting further guidance after UK health officials have given the green light for a weight-loss jab to be used to prevent heart attacks and strokes in overweight people. Semaglutide, sold under the brand name Wegovy, has already been approved for weight management in people with obesity...
Continue Reading
Register free to get 10 premium articles/month.
Register NowSubscribe to get unlimited access
Subscribe NowAlready a subscriber? Login here